Hippo, Doma and Qomplx all agreed to merge with SPACs in early March, at a time when institutional investors were enthusiastically backing such deals at pumped up valuations.
InsurTech SPACs face nail-biting redemption votes
![Hippo qomplx doma logos NYC 2.jpg](https://assets.euromoneydigital.com/dims4/default/d9e46c3/2147483647/strip/true/crop/700x410+0+0/resize/840x492!/quality/90/?url=http%3A%2F%2Feuromoney-brightspot.s3.amazonaws.com%2F8f%2F25%2F9bd50cdf481ca815ef16027779d8%2Fhippo-qomplx-doma-logos-nyc-2.jpg)
Hippo, Doma and Qomplx all agreed to merge with SPACs in early March, at a time when institutional investors were enthusiastically backing such deals at pumped up valuations.